Viewing Study NCT03729804


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2025-12-25 @ 7:07 PM
Study NCT ID: NCT03729804
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-03
First Post: 2018-10-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)
Sponsor: University of Chicago
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module